Literature DB >> 23973317

Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions.

Dalila Mango1, Alessandra Bonito-Oliva, Ada Ledonne, Robert Nisticò, Valentina Castelli, Mauro Giorgi, Giuseppe Sancesario, Gilberto Fisone, Nicola Berretta, Nicola Biagio Mercuri.   

Abstract

In the present study, we found that PDE10A inhibitor papaverine, alone or in combination with the D1 receptor agonist SKF38393, did not change spontaneous IPSCs (sIPSCs) frequency or amplitude in the substantia nigra pars reticulata (SNpr). An increase in frequency, but not in amplitude, of sIPSCs was only observed when SKF38393 and PDE10A inhibitors were associated to perfusion with higher extracellular K(+). On the other hand, the amplitude of evoked IPSCs (eIPSCs) of the striato-nigral projection to SNpr, was increased in response to co-administration of SKF38393 and papaverine in normal extracellular potassium. Of note, both an increase in sIPSCs frequency and eIPSC amplitude could be obtained either by a robust stimulation of adenylyl cyclase (AC) with forskolin (10 μM) or by a lower dose of forskolin (1 μM) associated to PDE inhibition. We next investigated the effects produced by dopamine (DA) depletion in the striatum. Under this condition, SKF38393 alone increased either sIPSCs frequency and eIPSC amplitude. In addition, in the striatum of DA-depleted mice we found reduced PDE10A levels and higher cAMP-dependent phosphorylation in response to D1 receptor stimulation. In accordance with these biochemical data, perfusion with papaverine had no effect on the SKF38393-induced changes of IPSCs in slices of DA-depleted mice. These findings reveal a dynamic interplay between PDE10A activity, level of neuronal network depolarization and degree of dopaminergic tone in the ability of D1 receptors to facilitate the GABAergic transmission to SNpr neurons from the direct nigro-striatal pathway. This article is part of the Special Issue entitled 'The Synaptic Basis of Neurodegenerative Disorders'.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AC; ACSF; D1 receptors; D1Rs; DA; DA- and cAMP-regulated phosphoprotein of 32 kDa; DARPP-32; Direct pathway; Dopamine; Forskolin; GABAA IPSCs; IEI; MSNs; PDE; PKA; PP; SCH; SCH23390; SKF; SKF38393; SNpr; Substantia nigra pars reticulata; adenylyl cyclase; artificial cerebrospinal fluid; cAMP; cAMP-dependent protein kinase; cyclic adenosine monophosphate; dopamine; eIPSCs; evoked IPSCs; forskolin; fsk; inter-event interval; medium-spiny neurons; paired pulse; papav; papaverine; phosphodiesterase; sIPSCs; spontaneous IPSCs; substantia nigra pars reticulata

Mesh:

Substances:

Year:  2013        PMID: 23973317     DOI: 10.1016/j.neuropharm.2013.08.010

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  9 in total

Review 1.  Synaptic plasticity may underlie l-DOPA induced dyskinesia.

Authors:  Anders Borgkvist; Ori J Lieberman; David Sulzer
Journal:  Curr Opin Neurobiol       Date:  2017-11-07       Impact factor: 6.627

2.  Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice.

Authors:  Xiomara A Perez; Danhui Zhang; Tanuja Bordia; Maryka Quik
Journal:  Mov Disord       Date:  2017-03-03       Impact factor: 10.338

3.  Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of DYT1 Dystonia.

Authors:  Vincenza D'Angelo; Valentina Castelli; Mauro Giorgi; Silvia Cardarelli; Ilaria Saverioni; Francesca Palumbo; Paola Bonsi; Antonio Pisani; Carmela Giampà; Roberto Sorge; Stefano Biagioni; Francesca R Fusco; Giuseppe Sancesario
Journal:  J Neurosci       Date:  2017-01-23       Impact factor: 6.167

4.  Loss of Striatonigral GABAergic Presynaptic Inhibition Enables Motor Sensitization in Parkinsonian Mice.

Authors:  Anders Borgkvist; Elizabeth M Avegno; Minerva Y Wong; Mazen A Kheirbek; Mark S Sonders; Rene Hen; David Sulzer
Journal:  Neuron       Date:  2015-09-02       Impact factor: 17.173

5.  Behavioral and qEEG effects of the PDE10A inhibitor THPP-1 in a novel rhesus model of antipsychotic activity.

Authors:  Joshua D Vardigan; Henry S Lange; Spencer J Tye; Steven V Fox; Sean M Smith; Jason M Uslaner
Journal:  Psychopharmacology (Berl)       Date:  2016-04-27       Impact factor: 4.530

6.  Selective Effects of PDE10A Inhibitors on Striatopallidal Neurons Require Phosphatase Inhibition by DARPP-32

Authors:  Marina Polito; Elvire Guiot; Giuseppe Gangarossa; Sophie Longueville; Mohamed Doulazmi; Emmanuel Valjent; Denis Hervé; Jean-Antoine Girault; Danièle Paupardin-Tritsch; Liliana R V Castro; Pierre Vincent
Journal:  eNeuro       Date:  2015-08-31

7.  Differential changes in amygdala and frontal cortex Pde10a expression during acute and protracted withdrawal.

Authors:  Marian L Logrip; Eric P Zorrilla
Journal:  Front Integr Neurosci       Date:  2014-04-08

Review 8.  Current Concepts on the Physiopathological Relevance of Dopaminergic Receptors.

Authors:  Ada Ledonne; Nicola B Mercuri
Journal:  Front Cell Neurosci       Date:  2017-02-08       Impact factor: 5.505

9.  Sex Differences in the Ventral Tegmental Area and Nucleus Accumbens Proteome at Baseline and Following Nicotine Exposure.

Authors:  Angela M Lee; Mohammad Shahid Mansuri; Rashaun S Wilson; TuKiet T Lam; Angus C Nairn; Marina R Picciotto
Journal:  Front Mol Neurosci       Date:  2021-07-14       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.